Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program-Reference-Cited by-同舟云学术

Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program

Published:2014-09-09 Issue:1 Volume:62 Page:65-71
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Carol Hernan¹,Fan Mannie M. Y.²,Harasym Troy O.²,Boehm Ingrid¹,Mayer Lawrence D.²,Houghton Peter³,Smith Malcolm A.⁴,Lock Richard B.¹

Affiliation:

1. Children's Cancer Institute Australia for Medical Research; University of New South Wales; Sydney NSW Australia

2. Celator Pharmaceuticals Corporation; Vancouver BC Canada

3. Nationwide Children's Hospital; Columbus OH

4. Cancer Therapy Evaluation Program; NCl; Bethesda MD

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25133/fullpdf

Reference38 articles.

1. Emerging therapy for the treatment of acute lymphoblastic leukemia;Fullmer;Expert Opin Emerg Drugs,2010

2. Adult acute lymphoblastic leukemia;Faderl;Cancer,2010

3. Howlader N Noone AM Krapcho M SEER Cancer Statistics Review, 1975-2010 National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/1975_2010/

4. Outcomes for children and adolescents with cancer: challenges for the twenty-first century;Smith;J Clin Oncol,2010

5. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG 2993 trial;Sive;Br J Haematol 2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology;European Journal of Medical Research;2024-04-09

2. Revisiting the in-vitro and in-vivo considerations for in-silico modelling of complex injectable drug products;Journal of Controlled Release;2023-08

3. Stealth and pseudo-stealth nanocarriers;Advanced Drug Delivery Reviews;2023-07

4. Current and emerging pharmacotherapy for the treatment of childhood acute myeloid leukemia;Expert Opinion on Pharmacotherapy;2022-11-13

5. An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia;Anti-Cancer Agents in Medicinal Chemistry;2022-09-14